Synchrony Financial Stock Could Rally Back Near Record Peak

Synchrony Financial (SYF) has struggled so far in 2026, last seen carrying a 6.3% deficit for January. A historically bullish trendline could help it bounce soon, though.

Will Lower Active Accounts Impact Synchrony's Q4 Earnings Potential?

SYF heads into Q4 with higher margins and purchase volumes, but declining active accounts and average interest-earning assets ...

Synchrony Financial: The Dip Made Valuation Synchronized With Fundamentals

Synchrony Financial upgraded to Buy: strong liquidity, credit quality, and PayPal partnership. Click here for more on the SYF ...

Wall Street's Insights Into Key Metrics Ahead of Synchrony (SYF) Q4 Earnings

Get a deeper insight into the potential performance of Synchrony (SYF) for the quarter ended December 2025 by going beyond ...
Powersports Business

Women’s Motocross Championship joins SMX for 2026 with Synchrony as presenting sponsor

Susan Medrano, senior vice president and general manager of Synchrony Outdoors, said the partnership aligns with the ...
American Banker

Synchrony's new CEO bets on health care, e-commerce to drive growth

Brian Doubles, the new CEO of Synchrony Financial, is focusing on partnerships with e-commerce companies and health care providers as the credit card issuer expects a resurgence in consumer spending.

Synchrony Financial: Trump's Credit Card Proposal Creates An Opportunity

Synchrony Financial stock is a "Buy" amid the sell-off due to Trump’s proposed 10% credit card APR cap. Learn more about the ...
Zacks Investment Research on MSN

WST launches Synchrony S1 prefillable syringe at Pharmapack

West Pharmaceutical Services WST recently announced the global commercial availability of the West Synchrony S1 prefillable ...